Factors influencing cancer risk perception in high risk populations: A systematic review

Hereditary Cancer in Clinical Practice

Volumn 9, Issue 1, 2011, Pages

  Tilburt, Jon C ^a   James, Katherine M ^a   Sinicrope, Pamela S ^a   Eton, David T ^a   Costello, Brian A ^a   Carey, Jantey ^a   Lane, Melanie A ^a   Ehlers, Shawna L ^a   Erwin, Patricia J ^b   Nowakowski, Katherine E ^a   Murad, Mohammad H ^a  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIETY; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER RISK; COGNITION; COPING BEHAVIOR; DISEASE SEVERITY; EMOTIONAL STRESS; ETHNICITY; FAMILY HISTORY; GENDER; GENETIC DISORDER; GENETIC SCREENING; GROUPS BY AGE; HEALTH BELIEF; HIGH RISK POPULATION; HUMAN; MINORITY GROUP; PERSONAL MONITORING; PERSONALITY; RISK ASSESSMENT; RISK FACTOR; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW;

SCOPUS;

EID: 80051775766     PISSN: 17312302     EISSN: 18974287     Source Type: Journal    
DOI: 10.1186/1897-4287-9-2     Document Type: Article

References (60)

1. Weinstein ND, Klein WM. Resistance of personal risk perceptions to debiasing interventions. Health Psychol 1995, 14(2):132-40.
2. Vernon SW. Risk perception and risk communication for cancer screening behaviors: a review. J Natl Cancer Inst Monogr 1999, 25:101-19.
3. Mellon S, Gold R, Janisse J, Cichon M, Tainsky MA, Simon MS, et al. Risk perception and cancer worries in families at increased risk of familial breast/ovarian cancer. Psycho-Oncology 2008, 17(8):756-66. 10.1002/pon.1370, 18613300.
4. Klein WM, Stefanek ME. Cancer risk elicitation and communication: lessons from the psychology of risk perception. CA Cancer J Clin 2007, 57(3):147-67. 10.3322/canjclin.57.3.147, 17507441.
5. Katapodi MC, Lee KA, Facione NC, Dodd MJ. Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic review. Prev Med 2004, 38(4):388-402. 10.1016/j.ypmed.2003.11.012, 15020172.
6. Edwards A, Elwyn G. Understanding risk and lessons for clinical risk communication about treatment preferences. Qual Health Care 2001, 10(Suppl 1):i9-13. 1765742, 11533431.
7. Stanton AL. Psychosocial concerns and interventions for cancer survivors. J Clin Oncol 2006, 24(32):5132-7. 10.1200/JCO.2006.06.8775, 17093275.
8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151(4):W64. 264-9.
9. Cappelli M, Surh L, Walker M, Korneluk Y, Humphreys L, Verma S, et al. Psychological and social predictors of decisions about genetic testing for breast cancer in high-risk women. Psychology, Health & Medicine 2001, 6(3):321-33.
10. Cappelli M, Verma S, Korneluk Y, Hunter D, Tomiak E, Allanson J, et al. Psychological and genetic counseling implications for adolescent daughters of mothers with breast cancer. Clinical Genetics 2005, 67(6):481-91. 10.1111/j.1399-0004.2005.00456.x, 15857415.
11. Martin W, Degner L. Perception of risk and surveillance practices of women with a family history of breast cancer. Cancer Nursing 2006, 29(3):227-35. 10.1097/00002820-200605000-00010, 16783123.
12. Matloff ET, Moyer A, Shannon KM, Niendorf KB, Col NF. Healthy women with a family history of breast cancer: Impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. Journal of Women's Health 2006, 15(7):843-56. 10.1089/jwh.2006.15.843, 21598432.
13. Salsman JM, Pavlik E, Boerner LM, Andrykowski MA. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer. Preventive Medicine 2004, 39(2):315-22. 10.1016/j.ypmed.2004.04.023, 15226040.
14. Blalock SJ, DeVellis BM, Afifi RA, Sandler RS. Risk perceptions and participation in colorectal cancer screening. Health Psychology 1990, 9(6):792-806.
15. Rimes KA, Salkovskis PM, Jones L, Lucassen AM. Applying a cognitive-behavioral model of health anxiety in a cancer genetics service. Health Psychology 2006, 25(2):171-80.
16. Glanz K, Grove J, Marchand LL, Gotay C. Underreporting of family history of colon cancer: Correlates and implications. Cancer Epidemiology Biomarkers and Prevention 1999, 8(7):635-9.
17. Codori AM, Petersen GM, Miglioretti DL, Larkin EK, Bushey MT, Young C, et al. Attitudes toward colon cancer gene testing: Factors predicting test uptake. Cancer Epidemiology Biomarkers and Prevention 1999, 8(4 II):345-51.
18. VanDijk S, Otten W, Zoeteweij MW, Timmermans DRM, Asperen CJV, Breuning MH, et al. Genetic counselling and the intention to undergo prophylactic mastectomy: Effects of a breast cancer risk assessment. British Journal of Cancer 2003, 88(11):1675-81. 10.1038/sj.bjc.6600988, 2377127, 12771979.
19. Zakowski SG, Valdimarsdottir HB, Bovbjerg DH, Borgen P, Holland J, Kash K, et al. Predictors of intrusive thoughts and avoidance in women with family histories of breast cancer. Annals of Behavioral Medicine 1997, 19(4):362-9. 10.1007/BF02895155, 9706363.
20. Bjorvatn C, Eide GE, Hanestad BR, Oyen N, Havik OE, Carlsson A, et al. Risk perception, worry and satisfaction related to genetic counseling for hereditary cancer. Journal of Genetic Counseling 2007, 16(2):211-22. 10.1007/s10897-006-9061-4, 17279329.
21. Emery J, Morris H, Goodchild R, Fanshawe T, Prevost AT, Bobrow M, et al. The GRAIDS trial: A cluster randomised controlled trial of computer decision support for the management of familial cancer risk in primary care. British Journal of Cancer 2007, 97(4):486-93. 10.1038/sj.bjc.6603897, 2360348, 17700548.
22. Lobb EA, Butow PN, Barratt A, Meiser B, Gaff C, Young MA, et al. Communication and information-giving in high-risk breast cancer consultations: Influence on patient outcomes. British Journal of Cancer 2004, 90(2):321-7. 10.1038/sj.bjc.6601502, 2409563, 14735171.
23. Watson M, Lloyd S, Davidson J, Meyer L, Eeles R, Ebbs S, et al. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer. British Journal of Cancer 1999, 79(5-6):868-74. 2362694, 10070883.
24. DiProspero LS, Seminsky M, Honeyford J, Doan B, Franssen E, Meschino W, et al. Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: Findings from a focus group and a needs-assessment survey. Canadian Medical Association Journal 2001, 164(7):1005-9. 80928, 11314429.
25. Elit L, Esplen MJ, Butler K, Narod S. Quality of life and psychosexual adjustment after prophylactic oophorectomy for a family history of ovarian cancer. Familial Cancer 2001, 1(3-4):149-56.
26. Hatcher MB, Fallowfield L, A'Hern R. The psychosocial impact of bilateral prophylactic mastectomy: Prospective study using questionnaires and semistructured interviews. BMJ 2001, 322(7278):76. 10.1136/bmj.322.7278.76, 26594, 11154619.
27. Vernon SW, Myers RE, . Li BCTaS Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer. Cancer Epidemiology Biomarkers and Prevention 2001, 10(1):35-43. Li BCTaS.
28. Lerman C, Kash K, Stefanek M. Younger women at increased risk for breast cancer: perceived risk, psychological well-being, and surveillance behavior. Journal of the National Cancer Institute Monographs 1994, 16:171-6.
29. Domanska K, Nilbert M, Soller M, Silfverberg B, Carlsson C. Discrepancies between estimated and perceived risk of cancer among individuals with hereditary nonpolyposis colorectal cancer. Genetic Testing 2007, 11(2):183-6. 10.1089/gte.2007.9999, 17627391.
30. Haas JS, Kaplan CP, Jarlais GD, Gildengoin V, Perez-Stable EJ, Kerlikowske K. Perceived risk of breast cancer among women at average and increased risk. Journal of Women's Health 2005, 14(9):845-51. 10.1089/jwh.2005.14.845, 21598432.
31. Rowe JL, Montgomery GH, Duberstein PR, Bovbjerg DH. Health locus of control and perceived risk for breast cancer in healthy women. Behavioral Medicine 2005, 31(1):33-40. 10.3200/BMED.31.1.33-42, 16078524.
32. Royak-Schaler R, Klabunde CN, Greene WF, Lannin DR, DeVellis B, Wilson KR, et al. Communicating breast cancer risk: patient perceptions of provider discussions. 2002, 7(2):2. Medscape Womens Health.
33. Codori AM, Waldeck T, Petersen GM, Miglioretti D, Trimbath JD, Tillery MA. Genetic counseling outcomes: perceived risk and distress after counseling for hereditary colorectal cancer. J Genet Couns 2005, 14(2):119-32. 10.1007/s10897-005-4062-2, 15959643.
34. Lebel S, Jakubovits G, Rosberger Z, Loiselle C, Seguin C, Cornaz C, et al. Waiting for a breast biopsy: Psychosocial consequences and coping strategies. Journal of Psychosomatic Research 2003, 55(5):437-43. 10.1016/S0022-3999(03)00512-9, 14581098.
35. Audrain J, Schwartz MD, Lerman C, Hughes C, Peshkin BN, Biesecker B. Psychological distress in women seeking genetic counseling for breast-ovarian cancer risk: The contributions of personality and appraisal. Annals of Behavioral Medicine 1997, 19(4):370-7. 10.1007/BF02895156, 9706364.
36. Andrykowski MA, Carpenter JS, Studts JL, Cordova MJ, Cunningham LLC, Beacham A, et al. Psychological impact of benign breast biopsy: A longitudinal, comparative study. Health Psychology 2002, 21(5):485-94.
37. Cunningham LL, Andrykowski MA, Wilson JF, McGrath PC, Sloan DA, Kenady DE. Physical symptoms, distress, and breast cancer risk perceptions in women with benign breast problems. Health Psychology 1998, 17(4):371-5.
38. Erblich J, Bovbjerg DH, Valdimarsdottir HB. Looking forward and back: Distress among women at familial risk for breast cancer. Annals of Behavioral Medicine 2000, 22(1):53-9. 10.1007/BF02895167, 10892528.
39. Collins V, Halliday J, Warren R, Williamson R. Cancer worries, risk perceptions and associations with interest in DNA testing and clinic satisfaction in a familial colorectal cancer clinic. Clinical Genetics 2000, 58(6):460-8.
40. Beebe-Dimmer JL, Wood DP, Gruber SB, Chilson DM, Zuhlke KA, Claeys GB, et al. Risk Perception and Concern among Brothers of Men with Prostate Carcinoma. Cancer 2004, 100(7):1537-44. 10.1002/cncr.20121, 15042690.
41. Bratt O, Damber JE, Emanuelsson M, Kristoffersson U, Lundgren R, Olsson H, et al. Risk perception, screening practice and interest in genetic testing among unaffected men in families with hereditary prostate cancer. European Journal of Cancer 2000, 36(2):235-41. 10.1016/S0959-8049(99)00272-5, 10741283.
42. Miller SM, Fleisher L, Roussi P, Buzaglo JS, Schnoll R, Slater E, et al. Facilitating informed decision making about breast cancer risk and genetic counseling among women calling the NCI's cancer information service. Journal of Health Communication 2005, 10(Suppl1):119-36.
43. Schwartz MD, Lerman C, Miller SM, Daly M, Masny A. Coping disposition, perceived risk, and psychological distress among women at increased risk for ovarian cancer. Health Psychology 1995, 14(3):232-5.
44. O'Neill SC, DeMarco T, Peshkin BN, Rogers S, Rispoli J, Brown K, et al. Tolerance for uncertainty and perceived risk among women receiving uninformative BRCA1/2 test results. American Journal of Medical Genetics, Part C: Seminars in Medical Genetics 2006, 142(4):251-9.
45. Quillin JM, McClish DK, Jones RM, Burruss K, Bodurtha JN. Spiritual coping, family history, and perceived risk for breast cancer - Can we make sense of it?. Journal of Genetic Counseling 2006, 15(6):449-60. 10.1007/s10897-006-9037-4, 17013546.
46. Schwartz MD, Hughes C, Roth J, Main D, Peshkin BN, Isaacs C, et al. Spiritual faith and genetic testing decisions among high-risk breast cancer probands. Cancer Epidemiology, Biomarkers & Prevention 2000, 9(4):381-5.
47. Gil F, Mendez I, Sirgo A, Llort G, Blanco I, Cortes-Funes H. Perception of breast cancer risk and surveillance behaviours of women with family history of breast cancer: A brief report on a Spanish cohort. Psycho-Oncology 2003, 12(8):821-7. 10.1002/pon.704, 14681955.
48. Fang CY, Miller SM, Malick J, Babb J, Engstrom PF, Daly MB. Psychosocial correlates of intention to undergo prophylactic oophorectomy among women with a family history of ovarian cancer. Preventive Medicine 2003, 37(5):424-31. 10.1016/S0091-7435(03)00163-4, 14572427.
49. Wellisch DK, Lindberg NM. A psychological profile of depressed and nondepressed women at high risk for breast cancer. Psychosomatics: Journal of Consultation Liaison Psychiatry 2001, 42(4):330-6.
50. Zikmund-Fisher BJ, Ubel PA, Smith DM, Derry HA, McClure JB, Stark A, et al. Communicating side effect risks in a tamoxifen prophylaxis decision aid: The debiasing influence of pictographs. Patient Education and Counseling 2008, 73(2):209-14. 10.1016/j.pec.2008.05.010, 2649664, 18602242.
51. Stefanek ME, Helzlsouer KJ, Wilcox PM, Houn F. Predictors of and satisfaction with bilateral prophylactic mastectomy. Prev Med 1995, 24(4):412-9. 10.1006/pmed.1995.1066, 7479633.
52. Bondy ML, Vogel VG, Haiabi S, Lustbader ED. Identification of women at increased risk for breast cancer in a population-based screening program. Cancer Epidemiology Biomarkers and Prevention 1992, 1(2):143-7.
53. Lipkus I, Klein W. Effects of communicating social comparison information on risk perceptions for colorectal cancer. Journal of Health Communication 2006, 11(4):391-407. 10.1080/10810730600671870, 16720537.
54. Cameron LD, Reeve J. Risk perceptions, worry, and attitudes about genetic testing for breast cancer susceptibility. Psychology and Health 2006, 21(2):211-30.
55. Madalinska JE, Hollenstein J, Bleiker E, Beurden MV, Valdimarsdottir HB, Massuger LF, et al. Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer. Journal of Clinical Oncology 2005, 23(28):6890-8. 10.1200/JCO.2005.02.626, 16129845.
56. Peterson SK, Pentz RD, Marani SK, Ward PA, Blanco AM, LaRue D, et al. Psychological functioning in persons considering genetic counseling and testing for Li-Fraumeni syndrome. Psycho-Oncology 2008, 17(8):783-9. 10.1002/pon.1352, 18688785.
57. Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E. Predictive testing for hereditary non-polyposis colorectal cancer: Motivation, illness representations and short-term psychological impact. Patient Education and Counseling 2004, 55(2):265-74. 10.1016/j.pec.2003.11.002, 15530764.
58. Bruno M, Tommasi S, Stea B, Quaranta M, Schittulli F, Mastropasqua A, et al. Awareness of breast cancer genetics and interest in predictive genetic testing: A survey of a southern Italian population. Annals of Oncology 2004, 15(Suppl. 1):i48-i54.
59. Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, et al. Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: Anxiety, risk perceptions, and quality of life. Gynecologic Oncology 2003, 89(3):440-6. 10.1016/S0090-8258(03)00147-1, 12798709.
60. VanOostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Broecker-Vriends AH, vanAsperen CJ, Sijmons RH, et al. Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Education and Counseling 2007, 65(1):58-68. 10.1016/j.pec.2006.05.006, 16872788.